The Administrative Core (Core A) has the following specific aims: (1) to provide scientific leadership and coordination of the Program Project activities, assuring achievement of our scientific goals while maximizing scientific collaboration;(2) to promote productive communication among the Investigators and staff in the Projects and Cores, between Project Leaders, External Scientific Advisors, Program Officers, and other NIAID staff members;and (3) to provide fiscal oversight, administrative support, and ensure regulatory and grant policy compliance. The Administrative Core will be led by the Principal Investigator, Dr. Leonidas Stamatatos, who will manage, oversee and coordinate the efforts of each participant in the Program Project, with the assistance of the Project Manager. A group of external Scientific advisors will be formed to oversee the scientific activities of the HIVRAD Program Project and provide advice and support. This Core will oversee all aspects of this HIVRAD Program Project including scientific issues, regulatory affairs, finance, communication, coordination and administration of each of the Cores and Projects. This Core will ensure that expenditures and projections are commensurate with the goals of the overall project;monitor the fiscal and functional aspects of all subcontracts;and coordinate with the Grants and Contracts Offices at participating Institutions for the disbursement, expenditure and accounting of grant funds. It will facilitate communication among Project and Core leaders, the external Scientific Advisory Board and the NIAID Program Officer overseeing this Program Project and it will coordinate the preparation and submission of annual scientific and financial reports and renewal applications.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program Projects (P01)
Project #
5P01AI094419-03
Application #
8463119
Study Section
Special Emphasis Panel (ZAI1-BP-A)
Project Start
2013-05-01
Project End
2016-04-30
Budget Start
2013-05-01
Budget End
2014-04-30
Support Year
3
Fiscal Year
2013
Total Cost
$133,848
Indirect Cost
$32,025
Name
Seattle Biomedical Research Institute
Department
Type
DUNS #
070967955
City
Seattle
State
WA
Country
United States
Zip Code
98109
Finton, Kathryn A K; Friend, Della; Jaffe, James et al. (2014) Ontogeny of recognition specificity and functionality for the broadly neutralizing anti-HIV antibody 4E10. PLoS Pathog 10:e1004403
Correia, Bruno E; Bates, John T; Loomis, Rebecca J et al. (2014) Proof of principle for epitope-focused vaccine design. Nature 507:201-6
Avnir, Yuval; Tallarico, Aimee S; Zhu, Quan et al. (2014) Molecular signatures of hemagglutinin stem-directed heterosubtypic human neutralizing antibodies against influenza A viruses. PLoS Pathog 10:e1004103
McGuire, Andrew T; Dreyer, Anita M; Carbonetti, Sara et al. (2014) HIV antibodies. Antigen modification regulates competition of broad and narrow neutralizing HIV antibodies. Science 346:1380-3
McGuire, Andrew T; Hoot, Sam; Dreyer, Anita M et al. (2013) Engineering HIV envelope protein to activate germline B cell receptors of broadly neutralizing anti-CD4 binding site antibodies. J Exp Med 210:655-63
Finton, Kathryn A K; Larimore, Kevin; Larman, H Benjamin et al. (2013) Autoreactivity and exceptional CDR plasticity (but not unusual polyspecificity) hinder elicitation of the anti-HIV antibody 4E10. PLoS Pathog 9:e1003639